M&A Deal Summary

Endo International Acquires DAVA Pharmaceuticals

On June 24, 2014, Endo International acquired life science company DAVA Pharmaceuticals for 575M USD

Acquisition Highlights
  • This is Endo International’s 6th transaction in the Life Science sector.
  • This is Endo International’s 6th largest (disclosed) transaction.
  • This is Endo International’s 10th transaction in the United States.
  • This is Endo International’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2014-06-24
Target DAVA Pharmaceuticals
Sector Life Science
Buyer(s) Endo International
Deal Type Add-on Acquisition
Deal Value 575M USD
Advisor(s) Oppenheimer & Co.
Jefferies (Financial)
Dechert (Legal)

Target

DAVA Pharmaceuticals

Fort Lee, New Jersey, United States
DAVA Pharmaceuticals Inc., a specialty pharmaceuticals company, is focused on developing and marketing a broad portfolio of pharmaceutical products. DAVA is aggressively building its product portfolio through a combination of acquisitions, strategic alliances, in-licensing transactions, partnerships and development. DAVA's headquarters is in Fort Lee, New Jersey.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Endo International

Dublin, Ireland
Category Company
Founded 1920
Sector Medical Products
Employees3,103
Revenue 2.9B USD (2020)
DESCRIPTION

Endo International is a pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, bladder cancer, prostate cancer and the early onset of puberty in children, or central precocious puberty (CPP). Endo International was incorporatted in 1920 and is based in Dublin, Ireland.

DEAL STATS #
Overall 11 of 16
Sector (Life Science) 6 of 11
Type (Add-on Acquisition) 11 of 15
State (New Jersey) 1 of 3
Country (United States) 10 of 14
Year (2014) 1 of 2
Size (of disclosed) 6 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-02-03 HealthTronics

Austin, Texas, United States

HealthTronics provides mobile equipment services, medical devices and information technology solutions to the urology industry. The company partners with physician groups to facilitate equipment ownership and to provide logistical support for mobile lithotripsy, laser and cryoablation units. In addition, HealthTronics offers a line of cryoablation devices as well as a urology-specific IT platform. HealthTronics was founded in 1972 and is based in Austin, Texas.

Sell $130M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-24 SOMAR

Benito Juarez , Mexico

SOMAR is a pharmaceutical company focused on the development, manufacture, and marketing of high-quality generic and branded generic products in Mexico. SOMAR focuses on a number of key primary care market segments including dermatology medications. SOMAR is based in Benito Juarez, Mexico.

Buy -
Mergr

Product

Company

Legal